CMB ASX · Health Care

Cambium Bio Ltd

Announcements, last 12 months: 41
Price sensitive, last 12 months: 10
Followed on InvestorPA: Low (Outside the 20% most-followed companies on InvestorPA)

Upcoming events

Mon 9 Nov 2026, 11:00 AM AEDT

2026 Annual General Meeting

Latest announcements

Released	Headline	Actions
8 Oct 2026, 10:20 AM	Access Letter and Online Meeting Guide
8 Oct 2026, 10:16 AM	Notice of Annual General Meeting and Proxy form
8 Oct 2026, 10:09 AM	Proposed issue of securities - CMB
30 Sep 2026, 9:18 AM	Corporate Presentation - September 2026
28 Sep 2026, 9:39 AM	Date of AGM and Closing Date for Director Nominations
24 Sep 2026, 9:11 AM	Notification of cessation of securities - CMB
23 Sep 2026, 10:10 AM	Notification regarding unquoted securities - CMB
16 Sep 2026, 12:03 PM	Cambium Bio Secures A$10.85 Million Funding Package Price sensitive
16 Sep 2026, 11:39 AM	Proposed issue of securities - CMB
16 Sep 2026, 9:52 AM	Notice of ceasing to be a substantial holder

Guidance history

28 Apr 2026

Cambium Bio is targeting the following key milestones for Elate Ocular®: First Patient In in H2 CY 2026, topline data in Q4 CY 2027, and a rolling BLA submission in mid-CY 2028.

Most followed in Health Care

PME Pro Medicus Ltd
AHC Austco Healthcare Ltd
CSL CSL Ltd
RMD Resmed Inc
TLX TELIX Pharmaceuticals Ltd
CGS Cogstate Ltd
ALC Alcidion Group Ltd
CSX Cleanspace Holdings Ltd

Follow CMB to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.